Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications
Bas W.G. van Rhijn(The Netherlands Cancer Institute), Theodorus van der Kwast(Erasmus MC), Tahlita C.M. Zuiverloon(Erasmus MC), Ellen C. Zwarthoff(Erasmus MC), Bharati Bapat(Mount Sinai Hospital), Liyang Liu(Mount Sinai Hospital), Mireía Musquera(Surgical Specialties (Canada)), Geert J.L.H. van Leenders(Erasmus MC), André N. Vis(Hôpitaux Universitaires Henri-Mondor), Egbert R. Boevé(Hôpitaux Universitaires Henri-Mondor), Adriaan C. Jöbsis(Hôpitaux Universitaires Henri-Mondor), Alexandre R. Zlotta(Mount Sinai Hospital), Wim J. Kirkels(Erasmus MC), Michael A.S. Jewett(Princess Margaret Cancer Centre)
Cited by 47
Related Papers
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654